$PPD News

Last published 3y ago

3y agoPPDFDA Approves First Oral Treatment for Postpartum DepressionFDA Press ReleasesToday, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults. PPD is a major depressive episode that typically occurs after childbirth but can also begin during the later stages of pregnancy. Until now, treatment for PPD was only available as an IV injection given by a health care provider in certain ...
3y agoPPDThorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization - NCT05841160ClinicalTrials.govEvaluate ecopipam's effect on the QTc interval after administration of therapeutic and supratherapeutic doses, compared to placebo as a negative control using C-QTc analysis., Evaluate the effect of ecopipam at a therapeutic dose on heart rate, Evaluate the effect of ecopipam at a therapeutic dose on PR interval, (and 76 more...)
3y agoPPDA Single and Multiple Dose of Rodatristat Ethyl in Healthy Adult Subjects to Evaluate the Effect of Food and Safety - NCT05684640ClinicalTrials.govPart 1 will evaluate the effect of a high-fat meal on the PK of rodatristat ethyl, rodatristat, and its metabolite(s) following single-dose administration of a rodatristat ethyl 600 mg dose, Part 2 will assess the PK of rodatristat ethyl, rodatristat, and metabolite(s) following multiple repeat doses of rodatristat ethyl at a supratherapeutic level, Part 1 will also evaluate the effect of a high-f ...
3y agoPPDDaratumumab in Primary Antiphospholipid Syndrome - NCT05671757ClinicalTrials.govThe proportion of participants in the dose escalation phase with at least one Dose Limiting Toxicity (DLT), The proportion of participants with the following Grade 3 or higher adverse events (AEs) related to daratumumab, The proportion of Grade 2 or higher adverse event (AEs) related to daratumumab, (and 9 more...)
3y agoPPDDrug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects - NCT05657613ClinicalTrials.govTo assess the effect of pacritinib on the systemic exposure of digoxin, midazolam omeprazole, rosuvastatin, caffeine and metformin, To assess the effect of pacritinib on the systemic exposure of digoxin, midazolam, omeprazole, rosuvastatin, caffeine, and metformin, To assess the effect of bosentan (CYP450 3A4 inducer) on the systemic exposure of multiple doses of pacritinib, (and 5 more...)
4y agoGSK PPDA Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants - NCT05602025ClinicalTrials.govMaximum observed plasma concentration (Cmax) of depemokimab, Area under the concentration-time curve from time zero extrapolated to infinity (AUC[0-inf]) of depemokimab, Area under the concentration time curve from time zero to time of last observed quantifiable concentration (AUC[0-t]) of depemokimab, (and 8 more...)
4y agoPPDCOVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study - NCT05518487ClinicalTrials.govThe proportion of participants who reach a SARS-CoV-2 S antibody level >5000 U/mL, Composite that includes death, graft loss, need for dialysis, and acute rejection, Death, (and 19 more...)
4y agoPPDA Phase 2 Evaluation of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members and Veterans With PTSD - NCT05422612ClinicalTrials.govCAPS-5-R Past Month total score at Week 12 (Final/ET Visit)., Columbia Suicide Severity Rating Scale (C-SSRS), Beck Depression Inventory Second Edition (BDI-II).
4y agoPPDPhase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) - NCT05270668ClinicalTrials.govIncidence of AE, SAE and AE leading to discontinuation, Annual change of forced vital capacity (FVC), Change of FVC, (and 3 more...)
4y agoPPDSaama Appoints Scott Rogers as Company's Chief Financial OfficerBusiness WireScott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers
4y agoPPD TMOThermo Fisher Scientific Completes Acquisition of PPD, Inc.PR NewswireWALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (NASDAQ:PPD), a leading global provider of clinical research se
4y agoPPDPPD Named to 'Best Workplaces in Greater China' for Second Consecutive YearBusiness WirePPD, Inc. (NASDAQ:PPD) was named one of the "Best Workplaces in Greater China™ 2021" by Great Place to Work® for successfully creating an inclusive workplace experience for employees. PPD has more than 20 years of experience in the Asia-Pacific re
4y agoPPDPPD Named 'Best Vaccine CRO of the Year' in Asia-PacificBusiness WirePPD, Inc. (NASDAQ:PPD) was named "Best Vaccine CRO of the Year" at the Asia-Pacific Vaccine Excellence Awards 2021 for its strong presence, extensive experience and quality delivery in the Asia-Pacific (APAC) region. The award recognizes the contract
4y agoPPDPPD Wins Multiple Awards at Clinical Researcher of the Year CompetitionBusiness WirePPD, Inc. (NASDAQ:PPD) earned numerous honors at the 2021 PharmaTimes Clinical Researcher of the Year-The Americas competition. Two PPD teams won gold, one team won silver and another team took home bronze. PPD clinical researchers also won silver and b
4y agoPPDA Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis - NCT05123703ClinicalTrials.govAnnualized relapse rate (ARR), Number of new or enlarging T2-hyperintense lesions (T2 lesions) as detected by brain MRI during the double-blind period, Number of new or enlarging T2 lesions by Week 96, (and 4 more...)
5y agoPPDA Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease - NCT05099770ClinicalTrials.govPrimary Composite Endpoint, Secondary Composite Endpoint
5y agoPPDPPD, Inc. (PPD) Q3 2021 Earnings Call TranscriptEarnings Call TranscriptsPPD earnings call for the period ending September 30, 2021.
5y agoPPDPPD Reports Third Quarter and Year-To-Date 2021 ResultsBusiness WirePPD, Inc. (NASDAQ:PPD), a leading global contract research organization, today reported its financial results for the third quarter ended September 30, 2021. Highlights Net authorizations growth of 12.7% over third quarter 2020 to $1,352.7 milli
5y agoPPDMedable Secures $304 Million in Funding at $2.1 Billion Valuation; New Round Co-Led by Blackstone Growth, GSR Ventures and Tiger GlobalBusiness WireFunding Will Help Medable Accelerate Drug Development Through Decentralized Clinical Trials Medable Inc., the leading cloud platform for patient-centered clinical research, today announced $304 million in Series D funding to accelerate global adoptio
5y agoPPDPPD Named Clinical Research Company of the Year for Second Consecutive YearBusiness WirePPD, Inc. (NASDAQ:PPD) was named "Clinical Research Company of the Year" at the 2021 PharmaTimes Clinical Researcher of the Year International competition in London. In addition to PPD winning the highest honor, individual PPD clinical researchers wo
5y agoPPDPPD Announces Third Quarter 2021 Earnings Conference CallBusiness WirePPD, Inc. (NASDAQ:PPD), a leading global contract research organization, will host a conference call on Thursday, October 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its third quarter 2021 financial results. Investors and other interested parties
5y agoPPDSociety for Clinical Research Sites Names PPD Winner of Prestigious Eagle AwardBusiness WirePPD, Inc. (NASDAQ:PPD) is the recipient of the 2021 Eagle Award from the Society for Clinical Research Sites (SCRS) for its commitment to advancing clinical research professionalism through strong site partnerships. The award, based on voting by rese
5y agoAEMD PPDAethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical ProgramsPR NewswireSAN DIEGO, Sept. 30, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (NASDA
5y agoPPDBenzydamine Oromucosal Solution in Oral Mucositis (BOOM) - NCT05055726ClinicalTrials.govNumber of responders, Number of compliant patients to Benzydamine treatment., Change score in the World Health Organization oral mucositis grading scale., (and 12 more...)
5y agoPPDPPD Earns Gold Award for Excellence in Employee Learning and DevelopmentBusiness WirePPD, Inc. (NASDAQ:PPD) has been recognized with two global excellence awards for its effective learning programs, honoring the company's high-performing employee development initiatives supporting delivery of global operational excellence and innovative
5y agoPPDPPD Receives Award Recognizing Employee Talent DevelopmentBusiness WirePPD, Inc. (NASDAQ:PPD) has been recognized as one of the best in the world for its successful employee learning and development programs by the Association for Talent Development (ATD), a global organization that empowers and supports professionals to d
5y agoPPDStudy to Assess Bioequivalence and Adhesion Properties Between Two Granisetron Transdermal Patches. - NCT05027646ClinicalTrials.govArea under the plasma concentration versus time curve AUC (0-t), Area under the plasma concentration versus time curve AUC (0-inf), Peak Plasma Concentration (Cmax), (and 7 more...)
5y agoPPDExtension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention - NCT05016661ClinicalTrials.govIncidence of Treatment Emergent Adverse Events, Change in Monthly Migraine Days, Percentage of Patients with Reduction in Mean Migraine Days (MMD), (and 5 more...)
5y agoPPDA Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab - NCT04998851ClinicalTrials.govProportion of infants with B cell levels (CD19+ cells) below the lower limit of normal (LLN), Estimated average oral daily infant dosage (ADID), B cell levels (CD19+ cells) in the infant, (and 10 more...)
5y agoPPDA Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy - NCT04998812ClinicalTrials.govProportion of infants with B cell levels (CD19+ cells) below the lower limit of normal (LLN), B cell levels (CD19+ cells) in the infant, Serum concentration of ocrelizumab in the umbilical cord blood at birth, (and 10 more...)
5y agoPPDPPD, Inc. (PPD) Q2 2021 Earnings Call TranscriptEarnings Call TranscriptsPPD earnings call for the period ending June 30, 2021.
5y agoPPDPPD Reports Second Quarter and Year-To-Date 2021 ResultsBusiness WirePPD, Inc. (NASDAQ:PPD), a leading global contract research organization, today reported its financial results for the second quarter ended June 30, 2021. Highlights Net authorizations growth of 58.4% over second quarter 2020 to $1,666.4 million,
5y agoPPDCOVID Protection After Transplant Pilot Study - NCT04969263ClinicalTrials.govProportion of participants who have a protective antibody response to the mRNA-based COVID-19 vaccine, Frequency of solicited local reactogenicity adverse events (AEs) to the mRNA-based COVID-19 vaccine, Frequency of solicited local allergic reaction adverse events (AEs) to the mRNA-based COVID-19 vaccine, (and 9 more...)
5y agoPPDPPD Recognized as a Best Place to Work in AsiaBusiness WirePPD, Inc. (NASDAQ:PPD) has been named one of the Best Workplaces in Asia™ by Great Place to Work®, a global authority on high-trust, high-performance workplace cultures. PPD has more than 20 years of experience in the Asia-Pacific region, includin
5y agoPPDPPD Announces Second Quarter 2021 Earnings Conference CallBusiness WirePPD, Inc. (NASDAQ:PPD), a leading global contract research organization, will host a conference call on Thursday, July 29, 2021, at 7 a.m. (U.S. Eastern Time) to discuss its second quarter 2021 financial results. Investors and other interested parties m
5y agoTMO KKR PPD CG+1Blackstone, Carlyle, H&F’s Medline Buyout Is No Old-Style LBOBloomberg
5y agoPPDPPD Named 'Most Innovative CRO' by Triangle Business JournalBusiness WireHonors PPD's development and implementation of innovative customer solutions during COVID-19 pandemic PPD, Inc. (NASDAQ:PPD) has been named "Most Innovative CRO" by North Carolina's Triangle Business Journal, recognizing the global contract research
5y agoBMY PPDSelective CD28 Blockade in Renal Transplant Recipients - NCT04903054ClinicalTrials.govMean Estimated Glomerular Filtration rate (eGFR) (MDRD), Proportion of Participants Who Remain Free of Biopsy Proven Acute T-Cell Mediated Rejection (aTCMR), Proportion of Participants Who Remain Free of Antibody-Mediated Rejection (ABMR), (and 22 more...)
5y agoPPDPPD Opens Multipurpose Clinical Research Laboratory in Suzhou, ChinaBusiness WireOffers bioanalytical, biomarker and vaccine sciences services for global and China-based customers PPD, Inc. (NASDAQ:PPD), a leading global contract research organization, held a grand opening ceremony for its new multipurpose laboratory in Suzhou, C
5y agoPPDCRO Leadership Awards Recognize PPD for Excellence for 10th Consecutive YearBusiness WirePPD, Inc. (NASDAQ:PPD) has been recognized for excellence in the CRO Leadership Awards for the 10th consecutive year, earning praise for its clinical research capabilities and customer compatibility in a survey of pharmaceutical and biotech professional
5y agoPPDPPD Named "Best CRO" at Vaccine Industry Excellence AwardsBusiness WirePPD, Inc. (NASDAQ:PPD) was named "Best Contract Research Organization" at the 14th annual Vaccine Industry Excellence (ViE) Awards during the 2021 World Vaccine Congress. Accelerated Enrollment Solutions (AES), a business of PPD, received the honor of "
5y agoPPDPPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing CapabilitiesBusiness WireAdding cell and gene therapy capabilities to support growing customer need PPD, Inc. (NASDAQ:PPD), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increa
5y agoPPDPPD, Inc. (PPD) Q1 2021 Earnings Call TranscriptEarnings Call TranscriptsPPD earnings call for the period ending March 31, 2021.
5y agoPPDPPD Inc to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / April 28, 2021 / PPD Inc (NASDAQ:PPD) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 28, 2021 at 8:00 AM Eastern Time. To listen to the event live or access a replay of
5y agoPPDPPD Reports First Quarter 2021 ResultsBusiness WirePPD, Inc. (NASDAQ:PPD), a leading global contract research organization, today reported its financial results for the first quarter ended March 31, 2021. Highlights Net authorizations growth of 39.3% over first quarter 2020 to $1,481.6 million,
5y agoKNL PPD STL WRIMoore Kuehn Encourages PPD, WRI, STL, and KNL Investors to Contact Law FirmGlobeNewswireNEW YORK, April 27, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair
5y agoPPDPPD and Science 37® Strengthen Collaboration to Advance Decentralized Clinical Trials and Accelerate DevelopmentBusiness WireInnovative approach enables PPD to deploy studies utilizing Science 37's SaaS Platform PPD, Inc. (NASDAQ:PPD), a leading global contract research organization (CRO), and Science 37, developer of the Decentralized Clinical Trial Operating System™ (D
5y agoABBV PPDStudy to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With Moderate to Severe Plaque Psoriasis - NCT04846959ClinicalTrials.govNumber of Participants with Major Congenital Malformation (MCM), Number of Participants with Minor Congenital Malformation, Number of Participants with Stillbirth, (and 8 more...)
5y agoPPDMedable Secures Another $78 Million Funding to Fuel Digital Innovation for Patient-Centered Drug DevelopmentBusiness WirePALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc. today announced $78 million in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc. ( ...
5y agoGILD CG PRAH TMO+1Thermo to Buy PPD for $17.4 Billion as Health Deals SoarBloomberg